Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Primary Purpose : Treatment
Allocation : Randomized
Interventional Model : Parallel Assignment
Masking : None (Open Label)
Primary outcome measures:
3-year progression-free survival (PFS).
The authors' conclusion was: This study shows that adding neoadjuvant chemotherapy (NAC) consisting of cisplatin and gemcitabine to standard Chemoradiotherapy is not superior and is possibly inferior to Chemoradiotherapy alone for treating locally advanced cervical cancer (LACC).
…